🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

15+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 15 of 15 recruiting trials for “von-hippel-lindau-disease”

Phase 3RecruitingNCT07405164 ↗

Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)

👨‍⚕️ Medical Director, Merck Sharp & Dohme LLC📍 4 sites📅 Started Mar 2026View details ↗
Phase 2RecruitingNCT07171905 ↗

CAT-VHL Exploring the Role of Carbonic Anhydrase IX as Diagnostic and Theranostic Target in Von-Hippel Lindau Disease

🏥 IRCCS Ospedale San Raffaele📍 1 site📅 Started Feb 2026View details ↗
Phase 1, PHASE2RecruitingNCT06735755 ↗

A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in Patients With Glycogen Storage Disease Type Ia (GSDIa)

🏥 Beam Therapeutics Inc.📍 3 sites📅 Started Dec 2024View details ↗
RecruitingNCT06636383 ↗

Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program

👨‍⚕️ Medical Director, Ultragenyx Pharmaceuticals Inc.📍 19 sites📅 Started Nov 2024View details ↗
NAEnrolling by InvitationNCT05737602 ↗

Promoting Stress Management and Resilience Among Individuals With Von Hippel- Lindau Disease

👨‍⚕️ Giselle Perez, PhD, Massachusetts General Hospital📍 1 site📅 Started Jul 2024View details ↗
Phase 2RecruitingNCT07167329 ↗

Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial

👨‍⚕️ José Claudio Casali da Rocha, Head of Oncogenetics📍 1 site📅 Started Jan 2024View details ↗
RecruitingNCT05955014 ↗

Data Collection Protocol for Patients With Von Hippel Lindau Disease

👨‍⚕️ Eric Jonasch, MD, ejonasch@mdanderson.org📍 1 site📅 Started Aug 2023View details ↗
RecruitingNCT06194669 ↗

Mechanisms of Somatic Mutation and Tumor Initiation in Pre-malignant Kidney Tubule Cells

👨‍⚕️ Irene Franco, PhD, IRCCS Ospedale San Raffaele📍 1 site📅 Started Jun 2023View details ↗
NARecruitingNCT05424016 ↗

Propranolol and Von Hippel-Lindau Disease

🏥 Assistance Publique - Hôpitaux de Paris📍 1 site📅 Started Jan 2023View details ↗
Phase 2RecruitingNCT04924075 ↗

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

👨‍⚕️ Medical Director, Merck Sharp & Dohme LLC📍 84 sites📅 Started Aug 2021View details ↗
Phase 2RecruitingNCT04074135 ↗

Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors

👨‍⚕️ Naris Nilubol, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Jun 2020View details ↗
RecruitingNCT01496625 ↗

National Eye Institute Biorepository for Retinal Diseases

👨‍⚕️ Tiarnan DL Keenan, M.D., National Eye Institute (NEI)📍 1 site📅 Started Jun 2012View details ↗
RecruitingNCT03749980 ↗

MyVHL: Patient Natural History Study

👨‍⚕️ Joshua Mann, MPH, VHL Alliance📍 1 site📅 Started Jan 2012View details ↗
RecruitingNCT02420067 ↗

Screening for Endolymphatic Sac Tumours (ELSTs) in Von Hippel-Lindau (vHL) Patients

👨‍⚕️ Marie Luise Bisgaard, M.D., Department of Cellular and Molecular Medicin, University of Copenhagen📍 1 site📅 Started Feb 2011View details ↗
NAEnrolling by InvitationNCT00102544 ↗

Use of Tracking Devices to Locate Abnormalities During Invasive Procedures

👨‍⚕️ Peter A Pinto, M.D., National Institutes of Health Clinical Center (CC)📍 1 site📅 Started Feb 2005View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →